Anticancer agent 175
Product Specifications
Target
Apoptosis, Reactive Oxygen Species
Related Pathways
Metabolism, Apoptosis, Immunology/Inflammation, NF-κB
Bioactivity
Anticanceragent 175 (complex 1) is a near-infrared luminescent therapeutic compound. It induces ROS accumulation, mitochondrial damage, disruption of the Bax/Bcl-2 balance, and apoptosis (apoptosis) in HepG2 cell lines.
Molecular Formula
C81H86F10IrN8O4P-
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb3009033-01 20 µg
Recombinant Human Small integral membrane protein 47 (SIM47), partial
Sign In for Pricing
View Details orb3009033-02 100 µg
Recombinant Human Small integral membrane protein 47 (SIM47), partial
Sign In for Pricing
View Details orb3009033-03 1 mg
Recombinant Human Small integral membrane protein 47 (SIM47), partial
Sign In for Pricing
View Details 
MBS2010764-01 0.01 mg
Recombinant S100 Calcium Binding Protein A8 (S100A8)
Sign In for Pricing
View Details MBS2010764-02 0.05 mg
Recombinant S100 Calcium Binding Protein A8 (S100A8)
Sign In for Pricing
View Details MBS2010764-03 0.1 mg
Recombinant S100 Calcium Binding Protein A8 (S100A8)
Sign In for Pricing
View Details